pSBI | ||||
Characteristic | Intervention | Control | Adjusted RR (95 % CI) of pSBI Intervention vs. Controla | Adjusted RR (95 % CI) of pSBI Intervention vs. Control w/adjustment for pretrial pSBI %a |
Pretrial, N | 29,783 | 33,900 | ||
pSBI, n (%) | 3702 (12.4) | 4814 (14.2) | 0.95 (0.75–1.21) | |
ACT period, N | 46,688 | 49,990 | ||
pSBI, n (%) | 6891 (14.8) | 6945 (13.9) | 1.01 (0.89–1.14) | 1.05 (0.92–1.20) |
< 25th Pc | 2718/10,479 (25.9) | 2818/10,726 (26.3) | 0.99 (0.89–1.11) | 1.03 (0.92–1.15) |
≥ 25th P | 4058/36,007 (11.3) | 4015/39,030 (10.3) | 1.10 (0.95–1.28) | 1.15 (0.98–1.35) |
pSBI and Death | ||||
Characteristic | Intervention | Control | Adjusted RR (95 % CI) of pSBI & death Intervention vs. Controla | Adjusted RR (95 % CI) of pSBI & death Intervention vs. Control w/adjustment for pretrial pSBI %a |
Pretrial, Nb | 29,780 | 33,892 | ||
Had pSBI and died, n (%) | 681 (2.3) | 829 (2.4) | 0.96 (0.87–1.07) | |
ACT period, N | 46,688 | 49,990 | ||
Had pSBI and died, n (%) | 1132 (2.4) | 1018 (2.0) | 1.16 (1.04–1.29) | 1.17 (1.04–1.30) |
< 25th Pc | 627/10,479 (6.0) | 601/10,726 (5.6) | 1.02 (0.90–1.16) | 1.03 (0.90–1.17) |
≥ 25th P | 405/36,007 (1.1) | 317/39,030 (0.8) | 1.36 (1.13–1.64) | 1.36 (1.12–1.65) |